Stealth BioTherapeutics

General Information


We are a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body’s main source of energy production and are critical for normal organ function. Dysfunctional mitochondria characterize a number of rare genetic diseases, collectively known as primary mitochondrial diseases, and are also involved in many common age-related diseases.

Employees: 57
Founded: 2006
Contact Information
Address 275 Grove Street, Suite 3-107, Newton, MA 02466, US
Phone Number (617) 600-6888
Web Address
View Prospectus: Stealth BioTherapeutics
Financial Information
Market Cap $413.3mil
Revenues $0 mil (last 12 months)
Net Income $-92.2 mil (last 12 months)
IPO Profile
Symbol MITO
Exchange NASDAQ
Shares (millions): 6.5
Price range $12.00 - $12.00
Est. $ Volume $78.0 mil
Manager / Joint Managers Jefferies/ Evercore ISI/ BMO Capital Markets
CO-Managers Nomura
Expected To Trade: 2/15/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change